Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

お友達を1人紹介するごとに10ドルの紹介料を獲得しましょう!

AbbVie Inc

AbbVie Inc

ABBV · NYSE
ABBV · NYSE
251.85
USD-6.14-2.38%

日付

銘柄

ヘッドライン

ソース

    AbbVie Earnings: Can Skyrizi and Rinvoq Replace Humira?

    Crypto Daily

      AbbVie shares fell after six-session winning streak

      SeekingAlpha

        AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics

        SeekingAlpha

          Week ahead: AMZN, GOOG, PLTR, AMD, PFE, DIS, PYPL, ABBV, QCOM, SMCI, MRK, PEP, UBER, PM - Seeking Alpha

          Seeking Alpha

            AbbVie says not in talks to buy Revolution Medicines - report

            SeekingAlpha

              Revolution Medicines jumps on report AbbVie nears takeover

              SeekingAlpha

                Key deals this week: Hawkins, Canada Goose, AbbVie, Verint and more

                SeekingAlpha

                  AbbVie closes Capstan Therapeutics acquisition

                  SeekingAlpha

                    Key deals this week: Chart Industries, Northwind Midstream, AbbVie, Palo Alto Networks and more

                    Seeking Alpha

                      Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks

                      SeekingAlpha

                        AbbVie in talks to acquire Gilgamesh in $1B deal - report

                        SeekingAlpha

                          AbbVie closes $200M Nimble Therapeutics acquisition

                          SeekingAlpha

                            STARTS NOW! Rebel Edge 🏴‍☠️1pm line up: U.S. crude oil prices are dropping due to weak demand from China and expected higher U.S. production after the election. WTI is notably lower, part of a wider commodity slump. Stocks $TSLA $COIN $ABBV $HOOD Sports Detroit's kicker makes 58… https://t.co/mZXNAn84q8 https://t.co/HBCDrov0gz

                            MarketRebels
                            @MarketRebels

                              Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

                              MarketWatch

                                M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more

                                SeekingAlpha

                                  AbbVie to buy Aliada Therapeutics for $1.4B in cash

                                  SeekingAlpha

                                    AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease

                                    MarketWatch

                                      AbbVie cuts 2024 profit forecast citing R&D expenses https://t.co/dRM9npoJjV https://t.co/QNrN3lsX7b

                                      Reuters
                                      @Reuters

                                        AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets https://t.co/s5PM7sArdj https://t.co/fmmnx6uJlG

                                        Reuters
                                        @Reuters

                                          AbbVie completes acquisition of Cerevel Therapeutics

                                          SeekingAlpha

                                            Cerevel Therapeutics ticks higher amid Nasdaq delisting notice for AbbVie deal

                                            SeekingAlpha

                                              Cerevel gains as AbbVie says it expects deal to close soon (update)

                                              SeekingAlpha

                                                Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie

                                                SeekingAlpha

                                                  AbbVie cuts 2024 profit forecast on R&D expenses https://t.co/WTkmzTGw1V https://t.co/EOEaZXsEJq

                                                  Reuters
                                                  @Reuters

                                                    Cerevel Therapeutics drops amid report on FTC review of AbbVie deal

                                                    SeekingAlpha

                                                      AbbVie buys bowel disease drug developer Celsius for $250M

                                                      SeekingAlpha

                                                        Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal

                                                        SeekingAlpha

                                                          AbbVie says FDA approves Skyrizi for ulcerative colitis

                                                          MarketWatch

                                                            Cerevel Therapeutics gains after AbbVie says making good progress with FTC

                                                            SeekingAlpha

                                                              $COR $UNH $ABBV $ACAD $NVS $REGN | After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February Cencora publicly acknowledged the breach on February 27 after filing a notice with government regulators. Despite… https://t.co/8qToXmkbOW https://t.co/h8ZQs2luQB

                                                              Benzinga
                                                              @Benzinga

                                                                Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

                                                                CNBC

                                                                  Landos shares rocket 170% on AbbVie takeover deal

                                                                  SeekingAlpha

                                                                    FDA grants full approval to AbbVie/ImmunoGen drug Elahere

                                                                    SeekingAlpha

                                                                      AbbVie plans to offer senior notes to fund Immunogen, Cerevel deals

                                                                      SeekingAlpha

                                                                        AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

                                                                        MarketWatch

                                                                          Cerevel, AbbVie get FTC Second Requests for more merger info

                                                                          SeekingAlpha

                                                                            AbbVie revises Q1 earnings outlook as ImmunoGen deal closes

                                                                            SeekingAlpha

                                                                              AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen

                                                                              MarketWatch

                                                                                ImmunoGen spikes as HSR waiting period for AbbVie deal expires

                                                                                SeekingAlpha

                                                                                  AbbVie – Cerevel deal reportedly followed unusual options trading

                                                                                  SeekingAlpha

                                                                                    AbbVie's $8.7 bln bet on Cerevel is risky but smart, analysts say https://t.co/eJNLf96jCm https://t.co/CVmzjEAVVM

                                                                                    Reuters
                                                                                    @Reuters

                                                                                      AbbVie – Cerevel M&A deal lifts Reviva, Karuna

                                                                                      SeekingAlpha

                                                                                        AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion - CNBC

                                                                                        CNBC

                                                                                          AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal

                                                                                          MarketWatch

                                                                                            Cerevel Therapeutics jumps after Abbvie agrees to $8.7B takeover (update)

                                                                                            SeekingAlpha

                                                                                              $ABBV $CERE | AbbVie Nears Roughly $8B For Drug Developer Cerevel -Reuters https://t.co/xdE6a1KvVM

                                                                                              Benzinga
                                                                                              @Benzinga

                                                                                                ImmunoGen downgraded on Wall Street expecting AbbVie deal success

                                                                                                SeekingAlpha

                                                                                                  AbbVie to acquire cancer drugmaker ImmunoGen for $10B cash

                                                                                                  SeekingAlpha

                                                                                                    AbbVie results beat expectations despite low-cost competition to blockbuster Humira

                                                                                                    MarketWatch

                                                                                                      AbbVie buys Parkinson's disease drug developer Mitokinin

                                                                                                      SeekingAlpha

                                                                                                      よくある質問

                                                                                                      AbbVieの今日の株価は何ですか?

                                                                                                      AbbVieの株式ティッカーは何ですか?

                                                                                                      ABBVの株価は上昇していますか?

                                                                                                      ABBVのアナリストの推奨は何ですか?

                                                                                                      ABBVの時価総額は何ですか?

                                                                                                      ABBVは財務報告書を公開していますか?

                                                                                                      ABBVの次の決算日はいつですか?

                                                                                                      ABBVの前四半期の収益は何でしたか?

                                                                                                      ABBVの前四半期の収益は何でしたか?

                                                                                                      ABBVの前四半期の純利益は何でしたか?

                                                                                                      ABBVは配当を支払いますか?

                                                                                                      ABBVには何人の従業員がいますか?

                                                                                                      ABBVのEBITDAは何ですか?

                                                                                                      ABBVの株をどうやって買いますか?

                                                                                                      ABBVの株に投資すべきですか?